Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Centro Hospitalar e Universitário de Coimbra

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Coimbra Hospital and University Centre, E.P.E. (CHUC) was established by Decree-Law No. 30/2011 of March 2 and comprises the following hospitals: Coimbra University Hospitals (HUC), General Hospital (HG), Pediatric Hospital (HP), Bissaya Barreto Maternity Hospital (MBB), Daniel de Matos Maternity Hospital (MDD), and Sobral Cid Hospital (HSC).CHUC’s mission is to provide high-quality, highly specialized healthcare within a framework of professional training, education, research, scientific knowledge, and innovation. It serves as a national and international referral center in areas recognized as centers of excellence.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Government hospital

Business Subcategory

Source: Google. Government hospital
Source: Google. Hospital
Source: Trial-derived.
94Total Trials
Source: Trial-derived.
35Recruiting Trials
Source: Trial-derived.
64Active Trials
Source: Trial-derived.
27Completed Trials
Source: Trial-derived.
137Unique Conditions
Source: Trial-derived.
80Unique Sponsors

Conditions

Source: Trial-derived. Ulcerative Colitis (4)Source: Trial-derived. Idiopathic Pulmonary Fibrosis (3)Source: Trial-derived. Non-Small Cell Lung Cancer (3)Source: Trial-derived. Bradycardia (2)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (2)Source: Trial-derived. Chronic Kidney Disease (2)Source: Trial-derived. Chronic Obstructive Pulmonary Disease (2)Source: Trial-derived. Chronic Spontaneous Urticaria (2)

Sponsors

Source: Trial-derived. Boehringer Ingelheim (11)Source: Trial-derived. Hoffmann-La Roche (7)Source: Trial-derived. Novo Nordisk A/S (5)Source: Trial-derived. Unidade Local de Saúde de Coimbra, EPE (5)Source: Trial-derived. Bayer (4)Source: Trial-derived. Amgen (3)Source: Trial-derived. Bristol-Myers Squibb (3)Source: Trial-derived. Takeda (3)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. Spirometry
Source: AI-inferred. PET-CT
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. ETDRS 4 m visual-acuity lane
Source: AI-inferred. Echocardiography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Flow Cytometry
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. 3D digital skin imaging
Source: AI-inferred. Blood-based pharmacodynamic biomarker testing
Source: AI-inferred. Brain imaging
Source: AI-inferred. Dietitian-led dietary intake monitoring
Source: AI-inferred. Electronic participant diary (eDiary) system
Source: AI-inferred. Electronic patient diary (eDiary)
Source: AI-inferred. Electronic patient-reported outcome (eDiary) system